Literature DB >> 8497057

Adenovirus precursor to terminal protein interacts with the nuclear matrix in vivo and in vitro.

J N Fredman1, J A Engler.   

Abstract

The adenovirus precursor to the terminal protein (pTP), expressed in a vaccinia virus expression system or in native adenovirus, was assayed for its ability to interact with the nuclear matrix. Biochemical function was measured by determining the relative amount of pTP protein or of adenovirus DNA that remained associated with the nuclear matrix after extensive washing. pTP was retained on the matrix whereas beta-galactosidase was not, as assayed by quantitative immunoblot analysis. Nuclear matrix isolated from adenovirus-infected HeLa cells retained bound adenovirus DNA even when washed with 1 M guanidine hydrochloride; this interaction could be inhibited by added purified pTP protein. Analogous experiments with matrix isolated from HeLa cells infected with a recombinant vaccinia virus that expressed pTP showed a similar retention of pTP protein; this association could also be inhibited by added pTP protein. Binding of pTP to nuclear matrix isolated from uninfected cells was saturable, with an apparent Kd of 250 nM and an estimated 2.8 x 10(6) sites for pTP binding per cell nucleus. The association of pTP with matrix is postulated to help direct adenovirus replication complexes to the appropriate locale within the nucleus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497057      PMCID: PMC237682          DOI: 10.1128/JVI.67.6.3384-3395.1993

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Genetic evidence for multiple nuclear functions of the herpes simplex virus ICP8 DNA-binding protein.

Authors:  M Gao; D M Knipe
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

2.  Increase in a 55-kDa keratin-like protein in the nuclear matrix of rat liver cells during proliferative activation.

Authors:  R Aligué; R Bastos; J Serratosa; C Enrich; P James; C Pujades; O Bachs
Journal:  Exp Cell Res       Date:  1990-02       Impact factor: 3.905

3.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

4.  Functional interaction of nuclear transport-defective simian virus 40 large T antigen with chromatin and nuclear matrix.

Authors:  W Deppert; A Von Der Weth
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

5.  Codon insertion mutants of the adenovirus terminal protein.

Authors:  P I Freimuth; H S Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

6.  Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins.

Authors:  F D McKeon; M W Kirschner; D Caput
Journal:  Nature       Date:  1986 Feb 6-12       Impact factor: 49.962

7.  Organization and modulation of nuclear lamina structure.

Authors:  L Gerace; C Comeau; M Benson
Journal:  J Cell Sci Suppl       Date:  1984

8.  Encephalomyocarditis virus 3C protease: efficient cell-free expression from clones which link viral 5' noncoding sequences to the P3 region.

Authors:  G D Parks; G M Duke; A C Palmenberg
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

9.  Identification of two nuclear subclasses of the adenovirus type 5-encoded DNA-binding protein.

Authors:  K Voelkerding; D F Klessig
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

10.  Core filaments of the nuclear matrix.

Authors:  D C He; J A Nickerson; S Penman
Journal:  J Cell Biol       Date:  1990-03       Impact factor: 10.539

View more
  23 in total

1.  Optimization of the helper-dependent adenovirus system for production and potency in vivo.

Authors:  V Sandig; R Youil; A J Bett; L L Franlin; M Oshima; D Maione; F Wang; M L Metzker; R Savino; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Viral terminal protein directs early organization of phage DNA replication at the bacterial nucleoid.

Authors:  Daniel Muñoz-Espín; Isabel Holguera; David Ballesteros-Plaza; Rut Carballido-López; Margarita Salas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

3.  Anchorage of adenoviral RNAs to clusters of interchromatin granules.

Authors:  S Besse; F Puvion-Dutilleul
Journal:  Gene Expr       Date:  1995

4.  Adenovirus preterminal protein binds to the CAD enzyme at active sites of viral DNA replication on the nuclear matrix.

Authors:  P C Angeletti; J A Engler
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

5.  Adenovirus DNA polymerase: domain organisation and interaction with preterminal protein.

Authors:  E J Parker; C H Botting; A Webster; R T Hay
Journal:  Nucleic Acids Res       Date:  1998-03-01       Impact factor: 16.971

6.  Domain organization of the adenovirus preterminal protein.

Authors:  A Webster; I R Leith; R T Hay
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Role of preterminal protein processing in adenovirus replication.

Authors:  A Webster; I R Leith; J Nicholson; J Hounsell; R T Hay
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  Nuclear import of moloney murine leukemia virus DNA mediated by adenovirus preterminal protein is not sufficient for efficient retroviral transduction in nondividing cells.

Authors:  A Lieber; M A Kay; Z Y Li
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 9.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

10.  Functional Implications in Apoptosis by Interferon Inducible Gene Product 1-8D, the Binding Protein to Adenovirus Preterminal Protein.

Authors:  Insil Joung; Peter C Angeletti; Jeffrey A Engler
Journal:  J Microbiol       Date:  2003       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.